Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone. (Q33371830)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone. |
scientific article |
Statements
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone (English)
Bart Barlogie
1 reference
Paul G Richardson
Kenneth C Anderson
James R Berenson
Seema Singhal
Sundar Jagannath
Gordan Srkalovic
SUMMIT/CREST Investigators
Dixie L Esseltine
David Irwin
David P Schenkein